FURTHER READING
Fix JA. Strategies for delivery of peptides utilizing absorption-
enhancing agents. Journal of Pharmaceutical Sciences 1996; 85 :
1282–5.
Goldberg M, Gomez-Orellana I. Challenges for the oral delivery
of macromolecules. Nature Reviews Drug Discovery 2003; 2 :
289–95.
Mahato RI, Narang AS, Thoma L, Miller DD. Emerging trends in oral
delivery of peptide and protein drugs. Critical Reviews in
Therapeutic Drug Carrier Systems2003; 20 : 153–2.
Mathiovitz E, Jacobs JS, Jong NS et al. Biologically erodable micros-
pheres as potential oral drug delivery systems. Nature1997; 386 :
410–14.
Rowland M, Tozer TN. Clinical pharmacokinetics: concepts and applica-
tions, 3rd edn. Baltimore, MD: Williams and Wilkins, 1995: 11–50.
Skyler JS, Cefalu WT, Kourides I A et al. Efficacy of inhaled human
insulin in type 1 diabetes mellitus: a randomized proof-of-concept
study. Lancet2001; 357 : 324–5.
Varde NK, Pack DW. Microspheres for controlled release drug deliv-
ery. Expert Opinion on Biological Therapy2004; 4 : 35–51.ROUTES OFADMINISTRATION 23